Joan Merrill's research topics

Joan Merrill

Concepts (757)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Joan Merrill's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Joan Merrill has written about over time.

Antiphospholipid Syndrome, 26 publications between 1996 and 2019, average publication date November 2004. Antibodies, Antiphospholipid, 18 publications between 1997 and 2021, average publication date March 2007. Antibodies, Monoclonal, 23 publications between 1990 and 2022, average publication date April 2011. Genetic Predisposition to Disease, 49 publications between 2004 and 2018, average publication date November 2011. Polymorphism, Single Nucleotide, 48 publications between 2007 and 2018, average publication date December 2011. Lupus Nephritis, 26 publications between 2005 and 2022, average publication date April 2012. Humans, 264 publications between 1979 and 2022, average publication date April 2012. Lupus Erythematosus, Systemic, 218 publications between 1995 and 2022, average publication date May 2013. Double-Blind Method, 31 publications between 2001 and 2022, average publication date July 2013. Female, 168 publications between 1997 and 2022, average publication date August 2013. Male, 139 publications between 1997 and 2022, average publication date November 2013. Adult, 133 publications between 1994 and 2022, average publication date February 2014. Middle Aged, 97 publications between 1997 and 2022, average publication date June 2014. Severity of Illness Index, 58 publications between 2004 and 2022, average publication date October 2014. B-Cell Activating Factor, 14 publications between 2005 and 2022, average publication date January 2015. Biomarkers, 31 publications between 2000 and 2022, average publication date February 2015. Antibodies, Monoclonal, Humanized, 27 publications between 2008 and 2022, average publication date June 2015. Quality of Life, 19 publications between 2007 and 2021, average publication date December 2015. Immunosuppressive Agents, 20 publications between 2005 and 2022, average publication date April 2016. Recombinant Fusion Proteins, 7 publications between 2015 and 2021, average publication date October 2018.

Antiphospholipid Syndrome
Antibodies, Antiphospholipid
Antibodies, Monoclonal
Genetic Predisposition to Disease
Polymorphism, Single Nucleotide
Lupus Nephritis
Humans
Lupus Erythematosus, Systemic
Double-Blind Method
Female
Male
Adult
Middle Aged
Severity of Illness Index
B-Cell Activating Factor
Biomarkers
Antibodies, Monoclonal, Humanized
Quality of Life
Immunosuppressive Agents
Recombinant Fusion Proteins

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Antiphospholipid Syndrome	26	1996	2019	November 2004
Antibodies, Antiphospholipid	18	1997	2021	March 2007
Antibodies, Monoclonal	23	1990	2022	April 2011
Genetic Predisposition to Disease	49	2004	2018	November 2011
Polymorphism, Single Nucleotide	48	2007	2018	December 2011
Lupus Nephritis	26	2005	2022	April 2012
Humans	264	1979	2022	April 2012
Lupus Erythematosus, Systemic	218	1995	2022	May 2013
Double-Blind Method	31	2001	2022	July 2013
Female	168	1997	2022	August 2013
Male	139	1997	2022	November 2013
Adult	133	1994	2022	February 2014
Middle Aged	97	1997	2022	June 2014
Severity of Illness Index	58	2004	2022	October 2014
B-Cell Activating Factor	14	2005	2022	January 2015
Biomarkers	31	2000	2022	February 2015
Antibodies, Monoclonal, Humanized	27	2008	2022	June 2015
Quality of Life	19	2007	2021	December 2015
Immunosuppressive Agents	20	2005	2022	April 2016
Recombinant Fusion Proteins	7	2015	2021	October 2018